Brought to you by 
Edwards Lifesciences licenses CardioFocus' cardiac arrhythmia technology; later acquires business outright
04 Apr 2016
Executive Summary
Edwards Lifesciences (devices to treat late-stage cardiovascular disease) signed an exclusive multi-year agreement to market surgical devices for treating arrythmias, based on CardioFocus' surgical photonic ablation technology. They will also collaborate to develop additional products for cardiac surgery.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Edwards Lifesciences licenses CardioFocus' cardiac arrhythmia technology; later acquires business outright
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice